- 专利标题： Hendra virus recombinant compositions and uses thereof
-
申请号： US15233013申请日： 2016-08-10
-
公开(公告)号： US10350287B2公开(公告)日： 2019-07-16
- 发明人: Jean-Christophe Audonnet , Jules Maarten Minke , Teshome Mebatsion , Catherine Charreyre
- 申请人： BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
- 申请人地址： US GA Duluth
- 专利权人： BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
- 当前专利权人： BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
- 当前专利权人地址： US GA Duluth
- 代理商 Judy Jarecki-Black; Steffan Finnegan
- 主分类号： A61K39/155
- IPC分类号： A61K39/155 ; C07K14/005 ; A61K39/12 ; C12N7/00 ; A61K39/00
摘要：
The present invention provides vectors that contain and express in vivo or in vitro one or more Hendra virus polypeptides or antigens that elicit an immune response in animal or human against Hendra virus and Nipah virus, compositions comprising said vectors and/or Hendra virus polypeptides, methods of vaccination against Hendra virus and Nipah virus, and kits for use with such methods and compositions.
公开/授权文献
- US20170087242A1 HENDRA VIRUS RECOMBINANT COMPOSITIONS AND USES THEREOF 公开/授权日：2017-03-30
信息查询
